Tag: Cancer: Prostate

Adjuvant RT versus early salvage RT may lower the risk for all-cause mortality in men with adverse pathology at radical prostatectomy

Model combining measurement of EN2 protein marker and levels of 10 genes in urine could reduce unnecessary biopsies

Patients with breast, prostate cancer who are receiving hormonal therapy more likely to develop cardiovascular risk factors

Risk higher for men on alpha-blockers versus 5-alpha reductase inhibitors

In validation study, 3.7 percent of grade group ≥2 cancers missed with MyProstateScore value ≤10

Use of glycolysis-enhancing drugs terazosin, doxazosin, or alfuzosin tied to lower risk for developing Parkinson disease than use of tamsulosin

Across states, reductions in PSA screening linked to increased incidence of metastatic prostate cancer at diagnosis

In small phase II study, 93 percent free of clinically significant prostate cancer at treatment site at five-month biopsy

Risk lower for men with newly diagnosed prostate cancer on active surveillance protocol

Pooled relative risk of 0.988 for each increment of one cup of coffee per day revealed in meta-analysis of cohort studies